Rockwell Medical Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Rockwell Medical stock has a consensus rating of "Buy" and an average price target of $3.00. The average 1-year stock price forecast is 361.18% higher than the current stock price, while the lowest is $2.00 (+207.46%) and the highest is $4.00 (+514.91%).

Price Target: $3.00 (+361.18%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$3.00	$3.00	$4.00
Change	+207.46%	+361.18%	+361.18%	+514.91%

Analyst Ratings

The average analyst rating for Rockwell Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Nov '25	Jan '26	Mar '26	May '26
Strong Buy	0	0	1	1	1	1
Buy	2	2	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $2	Buy	Reiterates	$2	+207.46%	May 22, 2026
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $4	Buy	Maintains	$4	+514.91%	May 8, 2026

Financial Forecast

Revenue This Year

72.47M

from 69.26M

4.64%

from 69.26M

Revenue Next Year

78.29M

from 72.47M

8.03%

from 72.47M

EPS This Year

6.16

from -

EPS Next Year

7.26

from 6.16

17.86%

from 6.16

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	61.93M	72.81M	83.61M	101.49M	69.26M	72.47M
Revenue Growth	-0.43%	17.57%	14.84%	21.38%	-31.76%	4.64%
Gross Profit	-2.42M	4.08M	8.70M	17.48M	11.70M	13.84M
Gross Margin	-3.91%	5.60%	10.41%	17.23%	16.89%	19.10%
Operating Income	-30.34M	-16.78M	-6.67M	608.00K	-4.69M	-2.91M
Net Income	-32.67M	-18.68M	-8.44M	-480.00K	-5.31M	-3.53M
EPS	-	-	-	-	-	6.16
Forward PE	-	-	-	-	-	0.11
Free Cash Flow	-19.67M	-9.28M	-5.52M	2.09M	-1.52M	-600.00K
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	72.5M
Avg	72.5M
Low	72.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.7%
Avg	4.6%
Low	4.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	6.16
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	17.9%
Low	-